If your drug works by killing virus or blocking it from replicating, you’ve got to test it on *brand new* cases!
-
-
And the public only knows about hydroxychloroquine because there’s this one doc with a bee in his bonnet about it (and he’s probably biased and sloppy and goes to the media too early and exaggerates.)
Show this thread -
If it’s a cheap generic that *doesn’t* have a crazed fanboy, it’ll have even less apparent “success.” When was the last time you heard Discourse about indomethacin or niclosamide?
Show this thread -
If you don’t like that the “standard of care” is biased towards the interests of a handful of pharma companies...maybe the problem is that you need to be a hundred-billion-dollar company to run a clinical trial that satisfies today’s FDA?
Show this thread
End of conversation
New conversation -
-
-
but Gilead didn’t even pay for the remdesivir trial; NIH did. And there are 165 studies on clinical http://trials.gov for HCQpic.twitter.com/gt2QE28YUT
-
whoa, that is a lot of HCQ studies. I didn't know that. i was just going on bitter cynic priors. good to know!
End of conversation
New conversation -
-
-
I’m confused by this one. Aren’t there >100 hydroxychloroquine clinical trials? If you group all trials by drug this is the #1 drug last time I checked...
-
not in COVID19 though right? It’s a malaria drug, I’m sure it’s very well studied for that
- 2 more replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.